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Short Communication
Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia
in vitro
J. Blatt', D. Rotenstein2 & S. DienesI
'Divisions ofHematology-Oncology and 2Endocrinology, Children's Hospital ofPittsburgh, 125 DeSoto Street,
Pittsburgh, PA 15213, USA.
Accumulating evidence suggests that normal and
malignant lymphoid cells, although not generally
thought of as target organs for sex hormones, may
interact with these substances. For example,
exogenous oestrogen adversely affects survival of
AKR mice with spontaneously occuring leukaemia
(Srinivasan et al., 1982). Moreover, this effect has
been postulated to be mediated by sex hormone
receptors which have been demonstrated in normal
human lymphocytes as well as human and murine
leukaemic lymphoblasts (Vigersky et al., 1981; Cole
et al., 1983; Danel et al., 1981; Salmon & Vistica,
1979). We studied the effects of oestradiol (E2),
tamoxifen (tam), a synthetic anti-oestrogen, and
dihydrotestosterone (DHT) on proliferation of
MOLT 4, a cell line derived from an adolescent
with acute lymphoblastic leukaemia (ALL).
MOLT 4, a commercially available cell line
derived from a 19-year old male with T-cell ALL
(gift from Dr. A. Winkelstein, Montefiore Hospital,
Pittsburgh, PA), was maintained in RPMI 1640-
10% foetal calf serum with 2mM glutamine and
1% antibiotics. In order to minimize problems
with sex steroids endogenous to foetal calf serum,
experiments were done after cells had been washed
twice in RPMI 1640 and resuspended in RPMI to
which 5% heat-inactivated serum from a castrate
horse was added, with glutamine and antibiotics.
Using standard radioimmunoassays (performed by
Dr. P. Lee, Division of Endocrinology, Children's
Hospital, Pittsburgh, PA), our batch of horse serum
was confirmed to have <1 ngml- I testosterone and
E2 (i.e.: <0.1 ngml - I or 10- 1M in a 5% solution).
Molt 4 cells (4 x 104 cells/well, final concentration
2 x l05ml- 1) were placed in microtitre wells.
Graded concentrations of E2 or DHT (final
concentration 10-7M-10-13M) were added.
Hormone concentrations were chosen which
spanned physiologic levels seen in adults,
adolescents or prepubertal children. Steroid was
dissolved in ethanol and diluted in RPMI 1640 to
the desired concentration. Tamoxifen, 10-7M once
or daily for 3 days (gift of Stuart Pharmaceuticals,
Wilmington, DE) also was added alone or in
combination with E2. Plates then were incubated at
37°C in 5% C02/95% air. Quadruplicate wells
from each group were examined daily for 5 days
starting 24h after the final dose of tam. The
concentration of viable cells per well was
determined by counting cells with a
haemocytometer using trypan blue exclusion and
results expressed as mean+s.d. for each group.
Values among groups were compared using Student
t tests.
To further evaluate the effect of E2 ±tam, nucleic
acid and protein synthesis by MOLT 4
lymphoblasts were examined by measuring [3H]-
thymidine, [3H]-uridine, or [14C]-leucine incor-
poration into DNA, RNA, or protein (respective
specific activities 6.7Cimmol-1, 39Cimmol-1,
346 mCimmol-1, New England Nuclear, Boston,
MA) in quadruplicate aliquots (final concentration
2 x 105ml-1) in the presence of graded
concentrations of sex steroid (10-7M-10-13M) in
microtitre wells. A single dose of tamoxifen
(10-7M) with or without E2 also was studied. Cells
were incubated with these substances for 1-4 days
at 37°C in 5% C02/95% air. Radiolabelled
nucleotides (final concentration 2uCiml-1) and/or
leucine (0.2pCi ml-1) were added 6h before
samples were harvested with cold TCA on glass
fiber filters using a "Mash" microharvester (Bellco
Glass Inc., Vineland, NJ). These were counted in a
liquid scintillation counter.
Because E2 and tam are thought to mediate their
effects via specific cytosol receptors for oestrogen,
we used a standard radioreceptor assay to look for
specific binding of E2 by MOLT 4 cells (O'Malley
& Hardman, 1975). Cytosolic fractions obtained by
dextran-coated charcoal from 8 x 108 cells were
incubated overnight in the cold with radiolabelled
E2 (5 nM) in the presence or absence of 100-fold
excess unlabelled steroid. After further charcoal
extraction, total and nonspecific binding were
compared by counting aliquots of cytosol in a
liquid scintillation counter.
The effects of E2 with or without tam on
proliferation are summarized in figure 1 (only
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witn incunation times. In general tnese were
maximal by 4 days. E2(0 -8M-10-12M) and tam
alone did little to MOLT 4 at any of the times
studied. The combination of the two substances
was markedly inhibitory to DNA and protein
synthesis (P<0.001 for each) and somewhat less so
to RNA synthesis. For example, in one
representative experiment, cpm per well after 4 days
incubation were for [3H]-thymidine: 1033+34,
950+35, 925+85, 445+50 respectively for the
control, E2, tam, E2+tam (P<0.001 for E2+tam
compared with the control); for [14C]-leucine:
1351+35, 1382+36, 1492+43, 646+70 (P<0.001
compared with the control); for [3H]-uridine:
568+30, 522+39, 497+59, 428+33 (P<0.05
compared with the control). Decreases in counts
were proportional to decreases in cell number, as
determined by the growth curves. No specific
binding of E2 could be demonstrated at the
concentration tested.
Among children with acute lymphoblastic
leukaemia, sex is know to influence the incidence of
the disease and its prognosis. ALL is seen with
increasing frequency in boys compared to girls after
the first year of life (Cooke, 1933); among patients
with T-cell ALL, 4/5 are pubertal males (Sen &
IRnre.ls197XA sirlk qrt mnre. li]k?lv to hnvi- _ _ ul)kJlWll, 17'J), 113 a ALJ 11u1. 1flly tJ 11aVS
2 _ prolonged disease-free survival than are boys
(Kersey et al., 1975), a finding which cannot be
o 1 2 3 4 5 6 attributed solely to the occurrence of testicular
Time (days) relapse.
Whether these observations can be explained by lure 1 Effect of E2±tam on growth of MOLT 4 an effect of sex steroids on metabolism of is. First cell counts were obtained one day after leukaemic cells is not clear. However, that this may dition of final dose of tam, or 72h after plating (see be the case is suggested by reports which have ]t):(ta) control; (0) E2; o0) taM E2+tam; documented the presence of receptors for sex
chtam x3a 10-7M. 2 steroids in such cells. For example, lymphoblasts
from 3/7 females (3 years-30 years, median age 4
years) and 2/9 males with ALL (6 months-16 years,
9M E2 shown). In control wells containing median age 11 years) expressed receptors for
mone-deficient horse serum only, MOLT 4 grew oestradiol (Cole et al., 1983)). The physiologic
a mean peak density of 4.1 x 106 cellsml- 6 significance of these receptors is unknown, although
s from the start of incubation (day 4 on graph). cases have been described in which malignant
ther E2 nor a single dose of tam altered growth lymphoid cells from patients with chronic
ves significantly. However, E2 in combination lymphocytic leukaemia (Rosen et al., 1982) and
i tam resulted in a day 4 mean cell density of Hodgkin's disease (Stark et al., 1981) both bear
roximately 2.2 x 106ml-l (P=0.01) compared oestrogen receptors and are inhibited by oestrogens
i controls. Three days of tam alone inhibited or their antagonists. The leukaemia of AKR mice
wth of MOLT 4 to a similar extent but with E2 also is known to be sex hormone-dependent
lted in 5 x 105 cellsml -1 (P<0.001) compared although the receptor status of those lymphoblasts
icontrol. All doses of E2 from 10-8M-10-12M has not been examined (Srinivasan et al., 1982).
similar effects. Lower concentrations had no Data presented in this paper suggest that
ct even in combination with tamoxifen. Higher physiologic concentrations of oestradiol, even as
centrations by themselves suppressed low as those present in prepubertal children, may
liferation. DHT had no effect on proliferation cause mild time dependent changes in nucleic acid
AOLT in this system (not shown). and protein synthesis by MOLT 4. However, there
he effects of E2 with or without tamoxifen on was no consistent effect on proliferation as
trporation of radiolabelled precursors varied measured in suspension cultures of this cell line
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either by E2 or DHT. Surprisingly, despite the
minimal effects of oestradiol or of tamoxifen alone,
the combination of the two resulted in marked
inhibition of growth. Multiple doses of tamoxifen
also inhibited growth but this effect was again
amplified when oestradiol was added.
The mechanism by which tamoxifen and
oestradiol act in combination to inhibit growth of
MOLT 4 is unclear. Our inability to detect
cytosolic binding of oestrogen under conditions that
have been sensitive enough to detect as few as 150
such receptors per cell suggests that cytotoxicity
may not be mediated by classical sex steroid
receptors. These findings are in agreement with
those of another report in which the effects of
oestradiol on L1210 leukaemia in mice were found
not to correlate with numbers of receptors (Salmon
& Vistica, 1979). Whatever the mechanism, the
phenomenon may be a more general one, not
specific for ALL. We recently have noted E2 and
tam to have a similar effect on neuroblastoma cells
in vitro (submitted for publication). Anecdotal
reports have suggested that hormonal
manipulations may be useful in the treatment of a
variety of lymphoid malignancies (Rosen et al.,
1982; Stark et al., 1981). Study of additional
leukaemic cell lines, both of T- and non-T-cell
phenotype, is necessary in order to further define
the therapeutic potential of tamoxifen in acute
lymphoblastic leukaemia.
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